Myths vs facts: CYP2C19 and Schlaf

A common myth is that CYP2C19 gene variants directly cause sleep disorders. In reality, CYP2C19 encodes a liver enzyme that metabolizes various drugs, including certain antidepressants (e.g., citalopram), proton pump inhibitors, and the sleep aid diazepam. Variants can alter how quickly these drugs are processed, which may indirectly affect sleep quality—for example, if a medication is less effective or causes side effects. However, without medication, CYP2C19 has no significant direct impact on sleep. Claims that CYP2C19 variants alone cause insomnia or sleep apnea are not supported by evidence. Sleep is regulated by a complex interplay of genetics, environment, behavior, and other genes (e.g., CLOCK, PER3). Consumer DNA tests often overstate the role of single genes. If you experience sleep issues, focus on proven factors like sleep hygiene, stress reduction, and medical evaluation—not on a single genetic test.